Elanco Animal Health Inc

ELANSEC EDGAR

Pharmaceutical PreparationsCIK: 1739104

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$4.4B	$4.4B	$4.8B	$4.8B	$3.1B
Cost of Goods and Services Sold	$1.9B	$1.9B	$2.1B	$1.7B	$1.5B
Gross Profit	$2.5B	—	—	—	—
Research and Development Expense	$327.0M	$321.0M	$369.0M	$329.0M	$270.0M
Selling, General and Administrative Expense	$1.3B	$1.3B	$1.4B	$997.0M	$760.0M
Operating Expenses	—	—	—	—	—
Interest Expense	—	—	$236.0M	$150.0M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$12.6B	$14.4B	$15.5B	$16.5B	$17.7B
Assets, Current	$3.2B	$3.4B	$3.3B	$3.3B	$3.4B
Cash and Cash Equivalents, at Carrying Value	$468.0M	$352.0M	$345.0M	$638.0M	$495.0M
Accounts Receivable, after Allowance for Credit Loss, Current	$805.0M	$842.0M	$797.0M	$833.0M	$872.0M
Inventory, Net	$1.6B	$1.7B	$1.5B	$1.4B	$1.6B
Liabilities	$6.5B	$8.1B	$8.2B	$9.0B	$9.2B
Liabilities, Current	$1.3B	$1.2B	$1.7B	$1.6B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$271.0M	$452.0M	$483.0M	-$41.0M	$224.0M
Net Cash Provided by (Used in) Investing Activities	-$169.0M	-$179.0M	-$530.0M	-$4.8B	-$235.0M
Net Cash Provided by (Used in) Financing Activities	-$83.0M	-$549.0M	$210.0M	$5.0B	-$305.0M
Payments to Acquire Property, Plant, and Equipment	$140.0M	$171.0M	$159.0M	$135.0M	$140.0M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)